{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:20:05Z","timestamp":1768461605872,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clineuro.2020.105811","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T12:21:56Z","timestamp":1584706916000},"page":"105811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Sarcoidosis of the central nervous system: Safety and efficacy of treatment, and experience of biological therapies"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-9011","authenticated-orcid":false,"given":"Desmond P.","family":"Kidd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2020.105811_bib0005","first-page":"45","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat. Rev."},{"key":"10.1016\/j.clineuro.2020.105811_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2040622318790197","article-title":"Epidemiology of sarcoidosis: current findings and future directions","volume":"9","author":"Arkema","year":"2018","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.clineuro.2020.105811_bib0015","first-page":"85","article-title":"Neurological complications of systemic sarcoidosis (Review)","volume":"20","author":"Kidd","year":"2003","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.clineuro.2020.105811_bib0020","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00415-018-8928-2","article-title":"Sarcoidosis of the central nervous system: clinical features, imaging and CSF results","volume":"265","author":"Kidd","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2020.105811_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12016-015-8492-9","article-title":"Treatment of sarcoidosis","volume":"49","author":"Baughman","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clineuro.2020.105811_bib0030","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.clineuro.2020.105811_bib0035","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.STR.19.12.1497","article-title":"Modification of the Rankin scale: recovery of motor function after stroke","volume":"19","author":"Bonita","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2020.105811_bib0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1212\/NXI.0000000000000270","article-title":"Optic neuropathy associated with systemic sarcoidosis","volume":"3","author":"Kidd","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2020.105811_bib0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.rdc.2015.08.012","article-title":"Corticosteroids in sarcoidosis","volume":"42","author":"Judson","year":"2016","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.clineuro.2020.105811_bib0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/1744666X.2016.1175301","article-title":"Biologic therapies in the treatment of sarcoidosis","volume":"12","author":"Saketkoo","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clineuro.2020.105811_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000003431","article-title":"Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil","volume":"87","author":"Bitoun","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.105811_bib0060","first-page":"70","article-title":"Infliximab for refractory sarcoidosis","volume":"18","author":"Baughman","year":"2001","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.clineuro.2020.105811_bib0065","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/01.WNL.0000034766.13282.33","article-title":"Refractory neurosarcoidosis responding to infliximab","volume":"59","author":"Pettersen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.105811_bib0070","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am. J. Respir. Care Med."},{"key":"10.1016\/j.clineuro.2020.105811_bib0075","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of Infliximab in extrapulmonary sarcoidosis: results from a randomized trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clineuro.2020.105811_bib0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jnnp.2008.149989","article-title":"Treatment of refractory neurosarcoidosis with Infliximab","volume":"81","author":"Santos","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2020.105811_bib0085","first-page":"275","article-title":"Anti-TNF\u03b1 therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review","volume":"32","author":"Riancho-Zarrabeita","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clineuro.2020.105811_bib0090","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.clineuro.2020.105811_bib0095","doi-asserted-by":"crossref","first-page":"286857","DOI":"10.1155\/2013\/286857","article-title":"Off-label uses of anti-TNF therapy in three frequent disorders: Beh\u0481et\u2019s disease, sarcoidosis, and non-infectious uveitis","volume":"2013","author":"Sanchez-Cano","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.clineuro.2020.105811_bib0100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1843.2009.01518.x","article-title":"Clinical outcomes in sarcoidosis after cessation of infliximab treatment","volume":"14","author":"Panselinas","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.clineuro.2020.105811_bib0105","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1183\/09031936.00055213","article-title":"Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis","volume":"43","author":"Vorselaars ADM","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.clineuro.2020.105811_bib0110","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00415-017-8444-9","article-title":"Long-term outcomes of refractory neurosarcoidosis treated with infliximab","volume":"264","author":"Cohen-Aubart","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2020.105811_bib0115","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/WNL.0000000000004644","article-title":"Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series","volume":"89","author":"Gelfrand","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2020.105811_bib0120","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00337-10","article-title":"Inflammatory profile and response to antitumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis","volume":"18","author":"Loza","year":"2011","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720301542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846720301542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:33:07Z","timestamp":1759588387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846720301542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":24,"alternative-id":["S0303846720301542"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105811","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoidosis of the central nervous system: Safety and efficacy of treatment, and experience of biological therapies","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2020.105811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105811"}}